Chemoinformaics analysis of 1-(7-Methoxy-9H-pyrido[3,4-b]indol-1-yl)ethan-1-one
| Molecular Weight | 240.262 | nRot | 2 |
| Heavy Atom Molecular Weight | 228.166 | nRig | 16 |
| Exact Molecular Weight | 240.09 | nRing | 3 |
| Solubility: LogS | -3.554 | nHRing | 2 |
| Solubility: LogP | 2.486 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 15 |
| nHA | 3 | APOL | 35.1855 |
| nHD | 1 | BPOL | 16.3525 |
| QED | 0.701 |
| Synth | 2.255 |
| Natural Product Likeliness | 0.223 |
| NR-PPAR-gamma | 0.141 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.048 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.906 |
| MDCK | 0.0000124 |
| BBB | 0.768 |
| PPB | 0.860688 |
| VDSS | 1.121 |
| FU | 0.123086 |
| CYP1A2-inh | 0.99 |
| CYP1A2-sub | 0.95 |
| CYP2c19-inh | 0.81 |
| CYP2c19-sub | 0.415 |
| CYP2c9-inh | 0.406 |
| CYP2c9-sub | 0.932 |
| CYP2d6-inh | 0.788 |
| CYP2d6-sub | 0.878 |
| CYP3a4-inh | 0.787 |
| CYP3a4-sub | 0.271 |
| CL | 4.95 |
| T12 | 0.374 |
| hERG | 0.048 |
| Ames | 0.902 |
| ROA | 0.972 |
| SkinSen | 0.705 |
| Carcinogencity | 0.795 |
| EI | 0.961 |
| Respiratory | 0.981 |
| NR-Aromatase | 0.532 |
| Antiviral | Yes |
| Prediction | 0.678313 |